Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

Project Astra uses your phone camera or camera-equipped glasses to see the world around it and analyze what it sees.

Isomorphic Labs, the four-year-old drug discovery start-up owned by Google parent Alphabet, will have an artificial intelligence-designed drug in trials by the end of this year, says its founder Sir ...

"Given that the companies behind the large language models have released them without sort of putting guardrails around their use and potential dual use by bad actors, what is the role of government?" ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...